Back to 
Ensign Peak Advisors, Inc
Ensign Peak Advisors, Inc
TNGX
15 quarters
Position history for Ensign Peak Advisors, Inc's holdings in Tango Therapeutics, Inc.
No. Ensign Peak Advisors exited its TNGX (Tango Therapeutics) position in Q1 2025. Its Q4 2024 13F listed 57,319 shares worth $177,116. Ensign Peak Advisors already held TNGX in its Q3 2021 13F, the earliest on record, and held it in 14 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$692,000
Total Shares Change
-53,500
Quarter-by-Quarter History
Other major holders of TNGX: RTW Investments, LP, BlackRock, Inc., FMR LLC, Farallon Capital Management, L.L.C., Goldman Sachs Group Inc.